Wenhong Chen – Trademark Portfolio
Entity Type: 01
Wenhong Chen holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 11 (Environmental Control) — 3 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 4 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include NEEMOR, KPNKKWY, ESGARDEN, and NEWVIVID. The owner is based in Quanzhou, Fujian.
Rm 104, Bldg 15, Houban Community
No. 71 Tian 'an North Rd., Fengze Dist.
Quanzhou, Fujian 362000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Wenhong Chen's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Wenhong Chen have?
Wenhong Chen has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.
What trademark classes does Wenhong Chen file in?
Wenhong Chen files trademarks across 4 Nice Classification classes. The most active classes are Class 11 (Environmental Control), Class 9 (Computers & Electronics), Class 20 (Furniture), Class 5 (Pharmaceuticals). Class 11 covers apparatus for lighting, heating, steam generating, cooking, refrigerating, drying.
What are Wenhong Chen's most well-known trademarks?
Wenhong Chen's registered trademark portfolio includes well-known marks such as NEEMOR, KPNKKWY, ESGARDEN, and NEWVIVID. These are among 6 currently registered trademarks in the portfolio.
What is Wenhong Chen's trademark registration success rate?
Wenhong Chen has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.